NewsUp one level
Continuing the nanomed series, Nicolas Gouze of the European Technology Platform Nanomedicine Secretariat discusses the potential impact of a new Nanomedicine Translation Hub – the consolidation of new infrastructures, programmes and projects to enhance the innovation capacity of SMEs and academia in order to accelerate the development of nanomedicines towards the market.
ETPN Member SINTEF uploaded a new offer for the call NMP-11-2015 in the ETPN Brokerage section.
Midatech Pharma acquires Q Chip to support novel delivery platforms and product developments in cancer, diabetes and ophthalmology
International Workshop on Multifunctional Nanotechnology for selective detection and elimination of cancer
The Final MultiFun 2015 Workshop will be held in Madrid, February 23-25th 2015 at IMDEA Nanoscience.
On 2 December 2014, the European & Developing Countries Clinical Trials Partnership (EDCTP) opened the first call for research proposals under its second programme dedicated to Diagnostic tools for poverty-related diseases.
The Call for Abstracts for the CRS Annual Meeting & Exposition, which will take place in Edinburgh on July 26th to 29th 2015 is now open. We remind you that in addition to the meeting's scientific programme, a mini-symposium will be organised for the first time by the ETPN in cooperation with CRS.
European Calls with Nanomedicine relevance are currently open. The ETP Nanomedicine supports the emergence of project proposals for the these calls by providing its members with an online platform for partnersearches.
The ETPN continues its collaboration and series of nanomedicine articles with the International Innovation magazine, with an overview of nanomedicine based solutions to treat arthritis.
Prof. Hui Ying Yang (University of Technology and Design, Singapore) and Prof. Michael McAlpine (Princeton University, USA) have been awarded with the 2014 Nanonica Prize
The Call for Papers, Posters and for Exhibitors for the upcoming European Summit for Clinical Nanomedicine is open online from 10th December 2014.
Prof. Dr. Meisel nominated as Chair of the ETPN Working Group on Nanotechnologies for Regenerative Medicine
The ETPN Executive Board elected Prof. Dr. Meisel, Director of Center of Neurosciences and Chair of Dept. of Neurosurgery, BG-Clinic Bergmannstrost Halle, as interim Chair for the RegMed WG.
BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced a joint research and development agreement with Merck, known as MSD outside the United States and Canada, through a subsidiary, to discover and develop novel nanomedicines for oncology.
EFPIA and the Innovative Medicines Initiative announced the launch of a €280 million Call for proposals for an Innovative Medicines Initiative (IMI) programme aimed to address the current Ebola crisis.
Preliminary information on the topics scheduled for launch under the second Call for proposals under IMI 2 is available
A major step in implementing the ETPN Translation Hub has been reached, with three European projects entering the finalisation stage of their EU Grant Agreements. The project ENATRANS is for networking of SMEs in the nano-biomedical sector and supporting the SMEs with getting their products from the laboratory phase to the clinical applications. The projects 'NANOFACTURING' and 'NANOPILOT' will establish pilot lines to scale-up the production of novel nanopharmaceuticals from the lab-scale to the quantities needed for clinical testing. This announcement took place during the ETPN Annual Event 2014 in San Sebastian, Spain.
2nd European workshop on novel aspects of Nanomedicine entitled "Nanomedicine Now - The Challenge to Translate Scientific Results to Applications for patients" will be held on Thursday, November 27th, 2014 at the Council of Europe in Strasbourg.
A brokerage event for the incoming H2020 NMBP work program is organized by the European Technology Platform NANOfutures with the collaboration of EUMAT and Manufuture and ETPN.
ETPN Annual Event 2014 Press Release: Setting up the next Nanomedicine priorities and services for the field until 2020
The European Technology Platform on Nanomedicine (ETPN) organises its 2014 Annual Event & General Assembly in San Sebastian, Spain. The event will take place on October 15th and 16th, kindly co-organised by the nanoBasque Agency (SPRI) and hosted by CIC nanoGUNE, the Basque nanoscience cooperative research centre.
An article published, by Tore Skotland, Tore-Geir Iversen and Kirsten Sandvig from the Centre for Cancer Biomedicine and the Institute for Cancer Research of the Oslo University Hospital and members of the European Technology Platform on Nanomedicine (ETPN) has been recently released.
Results from 2B3-201 Dose-ascending Trial Presented at Joint ACTRIMS/ECTRIMS Meeting
The ETPN continues its collaboration and series of nanomedicine articles with the International Innovation magazine, with an overview of nanomedicine based solutions to improve the diagnostics and therapy of Alzheimer's disease.
The Education in Nano Technologies (EduNano) projects is currently assessing industry employment needs and the needs of academic researchers through a survey with the goal to develop online courses.
SPIE Microtechnologies, the European meeting where the latest technologies and applications in nanotechnology, microtechnology, as well as bioMEMs, and medical microdevices, smart sensors and integrated circuits and systems are presented.
New position published in the Jobs' section: Marie Curie - Post-Doctoral Researcher in Drug Development
Procarta Biosystems Ltd, Norwich, UK, in collaboration with the Consorzio Interuniversitario Per Lo Sviluppo Dei Sistemi A Grande Interfase, Florence, Italy, University of East Anglia, Norwich, UK, and Nanovector, Turin, Italy, are looking to recruit an experienced researcher.
The ETPN released its Newsletter 3/2014, compiling internal news but also nanomedicine news, upcoming events, information on future calls, ...